Reports of cardiovascular and cerebrovascular events following usage of ephedrine and caffeine to deal with obesity have achieved sufficient frequency that FDA and the Federal Trade Fee have started to research the safety of this mix and also have issued warnings to customers. In addition, FDA has proposed new polices for your labeling of products